Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

por Rodriguez, María Jimena, Perrone, María Cecilia, Riggio, Marina, Palafox, Marta, Salinas, Valeria, Elia, Andrés, Salgueiro, Natali Daiana, Werbach, Andrea Eugenia, Marks, María Paula, Kauffman, Marcelo A., Vellón, Luciano, Serra, Violeta, Novaro, Virginia
Publicado 2023

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

por Elía, Andrés, Saldain, Leo, Vanzulli, Silvia I., Helguero, Luisa A., Lamb, Caroline A., Fabris, Victoria, Pataccini, Gabriela, Martínez-Vazquez, Paula, Burruchaga, Javier, Caillet-Bois, Ines, Spengler, Eunice, Acosta Haab, Gabriela, Liguori, Marcos, Castets, Alejandra, Lovisi, Silvia, Abascal, María F., Novaro, Virginia, Sánchez, Jana, Muñoz, Javier, Belizán, José M., Abba, Martín C., Gass, Hugo, Rojas, Paola, Lanari, Claudia
Publicado 2023